Results 171 to 180 of about 53,073 (361)

Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Aim Integration of locoregional treatments (LRTs) with atezolizumab plus bevacizumab (atezo/bev) has improved treatment outcomes, enabling an increasing number of patients with unresectable hepatocellular carcinoma (HCC) to achieve a complete response (CR). A comprehensive analysis of recurrence following CR may provide insights into prognosis.
Tasuku Nakabori   +11 more
wiley   +1 more source

Phagocytosis of Lymphocytes and Erythrocytes by B-Cell Lymphoma in a Patient With a Clinical Suspicion of Pure Red Cell Aplasia. [PDF]

open access: yesClin Case Rep
ABSTRACT Herein, we report a diagnostically challenging case of a B‐cell lymphoma initially masquerading as pure red cell aplasia (PRCA). The key to diagnosis was the unique finding of phagocytic activity (engulfing erythrocytes and lymphocytes) by atypical mature lymphocytes in both peripheral blood and bone marrow, accompanied by clinical signs of ...
Cao T, Li Y, Peng X.
europepmc   +2 more sources

RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES. [PDF]

open access: yes, 1964
HITCHCOCK, CR   +9 more
core   +1 more source

Flow Lectin Affinity Chromatography−A Model with Sambucus nigra Agglutinin

open access: bronze, 2017
M. Luísa S. Silva   +2 more
openalex   +1 more source

TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.

open access: yesBlood, 2014
Ju Shi   +6 more
semanticscholar   +1 more source

Ruxolitinib Suppresses Interferon‐γ‐Induced JAK/STAT Activation in Oral Keratinocytes

open access: yesClinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.
ABSTRACT Objectives The Janus kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway plays a crucial role in oral inflammatory diseases such as oral lichen planus (OLP) and periodontitis. Interferon‐gamma (IFN‐γ) is a cytokine that activates the JAK/STAT pathway.
Kim N. Stolte   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy